A Phase II Study of Binimetinib in Combination with Encorafenib in Adults with Recurrent BRAF V600-Mutated High-Grade Astrocytoma or other Primary Brain Tumor

Grant

Awarded By

Total Award Amount

  • 18000.00

    • Direct Costs

  • 12120.00

    • Sponsor Award Id

  • ABTC 1802

    • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Xiaosi Han   Investigator